861 related articles for article (PubMed ID: 26773767)
1. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM
J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767
[TBL] [Abstract][Full Text] [Related]
2. Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach.
Kooijmans SAA; Gitz-Francois JJJM; Schiffelers RM; Vader P
Nanoscale; 2018 Feb; 10(5):2413-2426. PubMed ID: 29334397
[TBL] [Abstract][Full Text] [Related]
3. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting.
Kooijmans SA; Aleza CG; Roffler SR; van Solinge WW; Vader P; Schiffelers RM
J Extracell Vesicles; 2016; 5():31053. PubMed ID: 26979463
[TBL] [Abstract][Full Text] [Related]
4. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.
Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S
Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290
[No Abstract] [Full Text] [Related]
5. Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display.
Antes TJ; Middleton RC; Luther KM; Ijichi T; Peck KA; Liu WJ; Valle J; Echavez AK; Marbán E
J Nanobiotechnology; 2018 Aug; 16(1):61. PubMed ID: 30165851
[TBL] [Abstract][Full Text] [Related]
6. Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery.
Pham TC; Jayasinghe MK; Pham TT; Yang Y; Wei L; Usman WM; Chen H; Pirisinu M; Gong J; Kim S; Peng B; Wang W; Chan C; Ma V; Nguyen NTH; Kappei D; Nguyen XH; Cho WC; Shi J; Le MTN
J Extracell Vesicles; 2021 Feb; 10(4):e12057. PubMed ID: 33643546
[TBL] [Abstract][Full Text] [Related]
7. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems.
Piffoux M; Silva AKA; Wilhelm C; Gazeau F; Tareste D
ACS Nano; 2018 Jul; 12(7):6830-6842. PubMed ID: 29975503
[TBL] [Abstract][Full Text] [Related]
8. Low concentration of polyethylene glycol facilitates separation of extracellular vesicles from bronchoalveolar lavage fluid.
Lee H; He X; Ni K; Carnino JM; Jin Y
Am J Physiol Lung Cell Mol Physiol; 2021 Apr; 320(4):L522-L529. PubMed ID: 33438468
[TBL] [Abstract][Full Text] [Related]
9. Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma
Patras L; Ionescu AE; Munteanu C; Hajdu R; Kosa A; Porfire A; Licarete E; Rauca VF; Sesarman A; Luput L; Bulzu P; Chiroi P; Tranca RA; Meszaros MS; Negrea G; Barbu-Tudoran L; Potara M; Szedlacsek S; Banciu M
Cancer Biol Ther; 2022 Dec; 23(1):1-16. PubMed ID: 34964693
[TBL] [Abstract][Full Text] [Related]
10. Hydrogel-Mediated Sustained Systemic Delivery of Mesenchymal Stem Cell-Derived Extracellular Vesicles Improves Hepatic Regeneration in Chronic Liver Failure.
Mardpour S; Ghanian MH; Sadeghi-Abandansari H; Mardpour S; Nazari A; Shekari F; Baharvand H
ACS Appl Mater Interfaces; 2019 Oct; 11(41):37421-37433. PubMed ID: 31525863
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol precipitation is an efficient method to obtain extracellular vesicle-depleted fetal bovine serum.
Wang P; Arntz OJ; Husch JFA; Kraan P M V; Beucken JJJPVD; van de Loo FAJ
PLoS One; 2023; 18(12):e0295076. PubMed ID: 38051739
[TBL] [Abstract][Full Text] [Related]
12. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity.
Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB
J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics.
Zeng F; Lee H; Allen C
Bioconjug Chem; 2006; 17(2):399-409. PubMed ID: 16536472
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology.
Martin Perez C; Conceição M; Raz R; Wood MJA; Roberts TC
Methods Mol Biol; 2022; 2383():119-141. PubMed ID: 34766286
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
18. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
[TBL] [Abstract][Full Text] [Related]
19. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
Ingato D; Lee JU; Sim SJ; Kwon YJ
J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
[TBL] [Abstract][Full Text] [Related]
20. Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery.
Mohammadi AH; Ghazvinian Z; Bagheri F; Harada M; Baghaei K
BioDrugs; 2023 May; 37(3):353-374. PubMed ID: 37093521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
